Annual Report FY 2024-25
We believe AI is a powerful enabler - one that, applied with precision and nuance, can drive lasting impact across the life sciences value chain. Our technology roadmap reflects this belief, guiding how we build and deploy solutions for our clients. With a GenAI-first approach and vast expertise, we empower our domain experts to seamlessly integrate AI into business operations, ensuring reliability, scalability, and long-term value.
We have a dedicated team focused on advancing the capabilities of our multi-agent orchestration platform, Cortex. In addition, a cross-functional group regularly collaborates with the Cortex team, business, engineering, and product teams to ensure seamless integration and alignment across initiatives.
We continue to upgrade our existing platforms by integrating GenAI-driven, agent-based workflows:
Our tools are complemented by our extensive data repository collected across the product lifecycle. This includes commercial content assets across regions and therapeutic areas, proprietary information taxonomies for machine learning, and detailed operational data. We also integrate real-world, clinical, commercial, prescription, and patient data to deliver solutions like HCP cohort analysis, forecasting, customer experience strategy, and market access. We continue to strengthen our repositories as we use them to train GenAI-based agents.
We have established procedures, including security systems like firewalls with password encryption, to minimize the risk of security breaches. Our information security management system complies with the requirements of ISO/IEC 27001:2013 and ISO/IEC27701:2019. We have also established guidelines that assist employees in ensuring data security including:
The Indegene Digital Summit, held virtually in October 2024, brought together participants from 100+ leading life sciences organizations worldwide. With over 30 global leaders speaking, the summit showcased real-world perspectives on key themes including GenAI, advanced analytics, technology transformation, Global Capability Centers (GCCs), and operational innovation across commercial, medical, and R&D / Clinical functions. At the same time, speakers emphasized that technology alone is not enough – successful transformation requires the right leadership mindset, organizational culture, and flawless execution.
Keynote Speakers
